Effect of Reslizumab in Chronic Rhinosinusitis
| Status: | Recruiting |
|---|---|
| Conditions: | Sinusitis |
| Therapuetic Areas: | Otolaryngology |
| Healthy: | No |
| Age Range: | 18 - 75 |
| Updated: | 2/3/2018 |
| Start Date: | June 2016 |
| End Date: | July 2019 |
| Contact: | Study Coordinator |
| Phone: | 925-935-2599 |
Efficacy of Reslizumab for the Treatment of Chronic Rhinosinusitis A Double Blind, Randomized, Placebo-controlled, Phase III Trial
The purpose of this study is to determine whether Reslizumab is effective for the treatment
of chronic sinusitis.
of chronic sinusitis.
Inclusion Criteria:
1. Written informed consent
2. Willingness and ability to comply with the requirements of the study
3. Female or male patients ages 18-75 at the time of screening
4. A diagnosis of chronic rhinosinusitis according to the clinical practice guideline
(update) of the American academy of otolaryngology - head and neck surgery
5. Elevated blood eosinophils
6. Significant findings on computed tomography (CT) scan
Exclusion Criteria:
1. Unable to sign informed consent form
2. A woman that is pregnant or nursing a child
3. Known hypersensitivity to Reslizumab
4. Active cigarette smoking in the year prior to screening
5. Known underlying immunodeficiency
6. History of alcohol or drug abuse in the year prior to screening
Other criteria may apply. Please contact the investigator for more information
We found this trial at
1
site
Click here to add this to my saved trials
